Paper6817367
Partial improvement in negative schizophrenic symptoms after amphetamine.
Angrist B and 4 others. Psychopharmacology (Berl), 1982. Cited by 90 papers, by iCite.
Cite this record
ConductScience Library. Partial improvement in negative schizophrenic symptoms after amphetamine. Papers, record 6817367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6817367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dextroamphetamine | Major topic |
| Schizophrenia | Major topic |
| Adult | |
| Humans | |
| Middle Aged | |
| Schizophrenic Psychology |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 793562 | Hyporesponsivity of chronic schizophrenic patients to dextroamphetamine. | Arch Gen Psychiatry | 1976 | https://conductscience.org/library/papers/793562 | PubMed |
| 2 | 6101544 | Molecular pathology of schizophrenia: more than one disease process? | Br Med J | 1980 | https://conductscience.org/library/papers/6101544 | PubMed |
| 3 | 6110217 | Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6110217 | PubMed |
| 4 | 4630714 | Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. | Arch Gen Psychiatry | 1973 | https://conductscience.org/library/papers/4630714 | PubMed |
| 5 | 4835986 | Central dopamine turnover in schizophrenic syndromes. | Arch Gen Psychiatry | 1974 | https://conductscience.org/library/papers/4835986 | PubMed |
| 6 | 4578719 | Behavioral effects of L-dopa in schizophrenic patients. | Psychopharmacologia | 1973 | https://conductscience.org/library/papers/4578719 | PubMed |
| 7 | 9266 | Clinical effect of L-dopa on schizophrenia. | Curr Ther Res Clin Exp | 1976 | https://conductscience.org/library/papers/9266 | PubMed |
| 8 | 706 | The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo. | Psychopharmacologia | 1975 | https://conductscience.org/library/papers/706 | PubMed |
| 9 | 1156113 | Cerebrospinal fluid amine metabolites in acute schizophrenia. | Arch Gen Psychiatry | 1975 | https://conductscience.org/library/papers/1156113 | PubMed |
| 10 | 4678309 | Effect of L-dopa in schizophrenia. | Folia Psychiatr Neurol Jpn | 1972 | https://conductscience.org/library/papers/4678309 | PubMed |
| 11 | 6102776 | Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6102776 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40064751 | Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models. | Pharmacol Rep | 2025 | https://conductscience.org/library/papers/40064751 | PubMed |
| 39205914 | Adjunctive methylphenidate extended release in patients with schizophrenia: Protocol of a single-centre fixed dose cross-over open-label trial to improve functional and cognitive outcomes. | Contemp Clin Trials Commun | 2024 | https://conductscience.org/library/papers/39205914 | PubMed |
| 26566609 | The early identification of psychosis: can lessons be learnt from cardiac stress testing? | Psychopharmacology (Berl) | 2016 | https://conductscience.org/library/papers/26566609 | PubMed |
| 23756608 | Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases. | Neuropsychopharmacology | 2013 | https://conductscience.org/library/papers/23756608 | PubMed |
| 21243081 | How have developments in molecular imaging techniques furthered schizophrenia research? | Imaging Med | 2009 | https://conductscience.org/library/papers/21243081 | PubMed |
| 19948149 | The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex. | Brain Res | 2010 | https://conductscience.org/library/papers/19948149 | PubMed |
| 18427784 | Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats. | Psychopharmacology (Berl) | 2008 | https://conductscience.org/library/papers/18427784 | PubMed |
| 17634412 | A review of the effects of modafinil on cognition in schizophrenia. | Schizophr Bull | 2007 | https://conductscience.org/library/papers/17634412 | PubMed |
| 17078926 | G protein-coupled receptors in major psychiatric disorders. | Biochim Biophys Acta | 2007 | https://conductscience.org/library/papers/17078926 | PubMed |
| 16001126 | The potential role of lamotrigine in schizophrenia. | Psychopharmacology (Berl) | 2005 | https://conductscience.org/library/papers/16001126 | PubMed |
| 15495131 | Amphetamines for schizophrenia. | Cochrane Database Syst Rev | 2004 | https://conductscience.org/library/papers/15495131 | PubMed |
| 12829420 | Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories. | Neurotox Res | 2002 | https://conductscience.org/library/papers/12829420 | PubMed |
| 12601500 | The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. | Psychopharmacology (Berl) | 2003 | https://conductscience.org/library/papers/12601500 | PubMed |
| 8741946 | Amphetamine and negative symptoms of schizophrenia. | Psychopharmacology (Berl) | 1996 | https://conductscience.org/library/papers/8741946 | PubMed |
| 3110848 | Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography. | Psychopharmacology (Berl) | 1987 | https://conductscience.org/library/papers/3110848 | PubMed |
| 2860683 | Amphetamine response and relapse risk after depot neuroleptic discontinuation. | Psychopharmacology (Berl) | 1985 | https://conductscience.org/library/papers/2860683 | PubMed |
| 1796130 | Mood responses of remitted schizophrenics to methylphenidate infusion. | Psychopharmacology (Berl) | 1991 | https://conductscience.org/library/papers/1796130 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6817367
GET https://conductscience.org/api/papers/v1/6817367/authors